[Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report]
- PMID: 22746051
- DOI: 10.11150/kansenshogakuzasshi.86.287
[Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report]
Abstract
We report a case of a 45-year-old Japanese man with AIDS-associated Kaposi's sarcoma (KS) involving skin, liver, and lungs. Antiretroviral therapy was started in conjunction with pegylated liposomal doxorubicin (PLD). A clinical response was observed initially, but symptoms recurred following cessation of medication. The chemotherapeutic agent was changed to paclitaxel (PTX), since the therapeutic response to PLD was reduced and the total dose reached the maximum dose of 500 mg/m2. The patient had a good response to PTX and tolerated the medication well. Symptoms did not recur after completing 8 courses of chemotherapy. PTX should be considered as an alternative agent in treating KS when there are problems with the use of PLD.
Similar articles
-
Paclitaxel for treating KS.Proj Inf Perspect. 1997 Nov;(23):15. Proj Inf Perspect. 1997. PMID: 11365372
-
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study.J Chemother. 2021 Sep;33(5):342-347. doi: 10.1080/1120009X.2021.1920248. Epub 2021 Jun 1. J Chemother. 2021. PMID: 34060438
-
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.Drugs. 2011 Dec 24;71(18):2531-58. doi: 10.2165/11207510-000000000-00000. Drugs. 2011. PMID: 22141391 Review.
-
Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.Anticancer Res. 2000 Mar-Apr;20(2B):1159-61. Anticancer Res. 2000. PMID: 10810414
-
Paclitaxel for AIDS-associated Kaposi's sarcoma.Expert Rev Anticancer Ther. 2005 Apr;5(2):215-9. doi: 10.1586/14737140.5.2.215. Expert Rev Anticancer Ther. 2005. PMID: 15877519 Review.
Cited by
-
Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells.Mol Biol Rep. 2014 Jan;41(1):19-24. doi: 10.1007/s11033-013-2811-0. Epub 2013 Nov 21. Mol Biol Rep. 2014. PMID: 24253898
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Medical